CAE Financial Overview and Strategic Outlook
OVERVIEW
Portfolio shaping: Focus on core markets with announced sale
of CAE Healthcare
Transaction Details
On October 24, 2023, CAE announced that we have reached a definitive agreement to sell CAE's
Healthcare business to Chicago-based Madison Industries for an enterprise value of C$311M, subject
to customary adjustments.
Valuation: ~11.4x LTM Q1-FY24A EBITDA and FY23A EBITDA of 14.4x.
Expected close: Q4 FY24*
Use of Proceeds
Sale proceeds will be principally used to accelerate deleveraging, as well as to support CAE's
continued focus on technology advancement, market leadership and cost optimization within its core
training and simulation markets
With a strong leadership team and execution of growth milestones, CAE Healthcare
well positioned to further drive patient safety and quality outcomes
*Subject to customary regulatory, and other approvals
7
CAE Inc. Proprietary Information and/or Confidential
CAEView entire presentation